GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytori Cell Research Institute Inc (TSE:3750) » Definitions » Book Value per Share

Cytori Cell Research Institute (TSE:3750) Book Value per Share : 円235.21 (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Cytori Cell Research Institute Book Value per Share?

Cytori Cell Research Institute's book value per share for the quarter that ended in Dec. 2023 was 円235.21.

During the past 12 months, Cytori Cell Research Institute's average Book Value Per Share Growth Rate was -29.80% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -19.40% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -8.90% per year. During the past 10 years, the average Book Value Per Share Growth Rate was -1.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Cytori Cell Research Institute was 13.40% per year. The lowest was -28.10% per year. And the median was -3.90% per year.

Cytori Cell Research Institute's current price is 円1015.00. Its book value per share for the quarter that ended in Dec. 2023 was 円235.21. Hence, today's PB Ratio of Cytori Cell Research Institute is 4.32.

During the past 13 years, the highest P/B Ratio of Cytori Cell Research Institute was 4.88. The lowest was 0.34. And the median was 1.06.


Cytori Cell Research Institute Book Value per Share Historical Data

The historical data trend for Cytori Cell Research Institute's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytori Cell Research Institute Book Value per Share Chart

Cytori Cell Research Institute Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Book Value per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 536.39 568.06 406.97 415.81 297.10

Cytori Cell Research Institute Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 334.87 297.10 279.04 247.45 235.21

Competitive Comparison of Cytori Cell Research Institute's Book Value per Share

For the Biotechnology subindustry, Cytori Cell Research Institute's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cytori Cell Research Institute's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cytori Cell Research Institute's PB Ratio distribution charts can be found below:

* The bar in red indicates where Cytori Cell Research Institute's PB Ratio falls into.



Cytori Cell Research Institute Book Value per Share Calculation

Cytori Cell Research Institute's Book Value Per Share for the fiscal year that ended in Mar. 2023 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(2,653-0)/9
=297.10

Cytori Cell Research Institute's Book Value Per Share for the quarter that ended in Dec. 2023 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(2,100-0)/9
=235.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


Cytori Cell Research Institute  (TSE:3750) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Cytori Cell Research Institute Book Value per Share Related Terms

Thank you for viewing the detailed overview of Cytori Cell Research Institute's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Cytori Cell Research Institute (TSE:3750) Business Description

Traded in Other Exchanges
N/A
Address
1-1-1 Otemachi, Otemachi Park Building, Chiyoda-ku, Tokyo, JPN, 100-0004
Cytori Cell Research Institute Inc developing a new clinical approach to cell therapy to provide better medical care to patients by providing medical care that responds to unmet medical needs based on innovative regenerative medicine. Its product pipeline includes Habeo; ECCO-50 and others.

Cytori Cell Research Institute (TSE:3750) Headlines

No Headlines